Machinefabriek Amersfoort
MBI financed through a sale and operational lease back of all the manufacturing assets.
Suir Pharma
Turnaround in insolvency of a former contract manufacturer of generic medicines.
Background
Machinefabriek Amersfoort has been a well known industrial company in Europe for heavy machined parts (up to 200 Tons) to the oil and gas, energy, shipbuilding, wind power, defence and plastic moulding industry. Located in the centre of the Netherlands serving clients globally. When the Marinoffs Group wanted to acquire Machinefabriek Amersfoort, the new owner approached Hilco for a financial solution. The management buy in (MBI) could be financed through a term loan which was backed by all movable assets.
Deal Type
MBI financed through a sale and operational lease back of all the manufacturing assets
Industry
Heavy machining
Funding
Transfer of funds in full at closing
Deal Value
> € 7 mln
Diligence to Close
100 days
Duration
12 months
Overview to Completion
Future cashflow analysis, valuation report of movable assets and set up of legal structure.
What We Did
Hilco was able to apply its expertise in equipment and asset valuation to develop and efficiently execute a financial solution that resulted in a multi-million euro acquisition of the company. The solution was delivered, executed, and completed within a period of 100-days.
Conclusion
The seller (MFA) as well as the buyer (Marinoffs Group) were very satisfied with our swift and direct approach. By purchasing the assets and ease them back to the new entity the seller got paid in full and the buyer was able to integrate the existing machining company into his group. All creditors were paid off and title in the movable assets transferred to Hilco.
MBI financed through a sale and operational lease back of all the manufacturing assets.
Turnaround in insolvency of a former contract manufacturer of generic medicines.